Learn the trade here. Make it on tradeMONSTER

Options trading ideas and advanced education for options investors.

Facebook Twitter RSS

Thursday, April 24, 2014


Under Armour draws upside bet

Thu 4:14 AM CT
The athletic-apparel retailer, which hit an all-time high a month ago, attracted a large bullish play ahead of its earnings report this morning.
Read on »


Durable goods, jobless data on tap

Thu 3:47 AM CT

The earnings calendar is heavy as well, with results from Caterpillar, GM, UPS, Verizon, Eli Lilly, Freeport-McMoRan, PulteGroup, D.R. Horton, Starwood, and American Airlines.


Equities break six-day win streak

Thu 3:16 AM CT

The Nasdaq 100 led the major indexes lower yesterday, but the CBOE Volatility Index posted only a fractional gain.


Bulls shopping at Abercrombie

Wed 12:20 PM CT

The apparel retailer has struggled along with other teen retailers in 2013 but has been trying to recover since December.


What's behind Eldorado put sale

Wed 11:10 AM CT

The gold miner has been trading in a relatively tight range, and put selling may be tied to stock in a larger volatility play.


Videocast: Traders sell VIX calls

Wed 11:06 AM CT

Group One's Jamie Tyrrell says traders are "selling the possibility of a big move" in the VIX in the next few weeks, led by a large sale of May 18 calls.


Largest option trades in equities

Wed 10:33 AM CT

Nearing the halfway mark in today's session, here are the individual equity names with the most call and put buying on optionMONSTER's ActionTracker data system.


Midday index, ETF option volumes

Wed 10:21 AM CT

Total option volume is running well below average at just 4.3 million contracts so far, with most of the action in the big indexes and ETFs, optionMONSTER data systems show.


Vote of confidence in Mexico fund

Wed 10:03 AM CT

The iShares Mexico Fund has been testing resistance in the last couple of weeks, and one trader apparently believes that current levels will hold.


Limited gains seen in SunEdison

Wed 9:03 AM CT

Shares of the silicon-wafer producer posted a five-year closing high a month ago but tested support at going into last week.


Cramer: Allergan in the crosshairs

Wed 8:08 AM CT

The company has developed incredible drugs by spending a huge amount of its revenues, far more than all of the old-line pharmas and more like a biotech.

More stories

Register to get a free subscription

optionMONSTER is home to some of the most respected analysts in the market. Sign up for free access to our expertise.

Register Now

Invest Like a Monster - Las Vegas: June 13-14

Learn to Trade

optionMONSTER features a unique education program led by Jon ('DRJ') and Pete Najarian. Tell us your trading goals, get the first two chapters of Jon and Pete's latest book, How We Trade Options.

Let's do it